Phase III Clinical Trial of Hepalatide in Patients With Chronic Hepatitis D

Clinical trial NCT07309380 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07309380
Sponsor: Shanghai HEP Pharmaceutical Co., Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Hepatitis D, Chronic

Start date: 2026-04-01
Primary completion: 2027-06-01
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.